PenderFund Capital Management’s Pear Therapeutics, Inc. Warrant PEARW Stock Holding History

PenderFund Capital Management’s Portfolio PEARW Stock Details PEARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-333	Closed	–	–	156
2023 Q1	$0	Hold	333	–	–	﹤0.01%	147
2022 Q4	$0	Hold	333	–	–	﹤0.01%	157
2022 Q3	$0	Hold	333	–	–	﹤0.01%	185
2022 Q2	$0	Hold	333	–	–	﹤0.01%	182
2022 Q1	$0	Hold	333	–	–	﹤0.01%	177
2021 Q4	$0	Hold	333	–	–	﹤0.01%	167
2021 Q3	$0	Hold	333	–	–	﹤0.01%	143
2021 Q2	$1K	Buy	+333	New	+$291	﹤0.01%	83

Other funds holding PEARW

Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

PenderFund Capital Management's PEARW Position: Q2 2023 in Review

PenderFund Capital Management sold out of Pear Therapeutics, Inc. Warrant (PEARW) in Q2 2023, closing a stake of 333 shares.

PenderFund Capital Management first reported a position in PEARW in Q2 2021 and held it in 8 quarters. The position peaked at $1K in Q2 2021. 2 funds tracked by Wall St. Rank hold PEARW as of Q2 2023.

PenderFund Capital Management reported no remaining Pear Therapeutics, Inc. Warrant position as of Q2 2023 after selling out during the quarter.
PenderFund Capital Management sold 333 Pear Therapeutics, Inc. Warrant shares in Q2 2023.
PenderFund Capital Management first reported a position in Pear Therapeutics, Inc. Warrant in Q2 2021 and held it in 8 quarters.
PenderFund Capital Management's Pear Therapeutics, Inc. Warrant position peaked at $1K in Q2 2021.
2 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Warrant as of Q2 2023.

Based on PenderFund Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.